Delayed
Warsaw S.E.
08:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
15.8
PLN
|
0.00%
|
|
-1.25%
|
+6.04%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
93.07
|
91.28
|
125.6
|
89.12
|
63.83
|
105.4
|
Enterprise Value (EV)
1 |
168.1
|
174.8
|
247.7
|
211.3
|
202.7
|
214.8
|
P/E ratio
|
15.1
x
|
7.5
x
|
11.3
x
|
17
x
|
-3.77
x
|
5.75
x
|
Yield
|
1.08%
|
2.67%
|
1.99%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.25
x
|
0.23
x
|
0.33
x
|
0.15
x
|
0.1
x
|
0.19
x
|
EV / Revenue
|
0.45
x
|
0.45
x
|
0.65
x
|
0.37
x
|
0.31
x
|
0.38
x
|
EV / EBITDA
|
6.44
x
|
6.02
x
|
7.62
x
|
8.62
x
|
14.3
x
|
3.42
x
|
EV / FCF
|
23.7
x
|
29.8
x
|
212
x
|
16.1
x
|
45.6
x
|
6.43
x
|
FCF Yield
|
4.23%
|
3.36%
|
0.47%
|
6.21%
|
2.19%
|
15.5%
|
Price to Book
|
0.83
x
|
0.74
x
|
0.95
x
|
0.66
x
|
0.55
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
7,159
|
7,159
|
7,159
|
7,129
|
7,077
|
7,077
|
Reference price
2 |
13.00
|
12.75
|
17.55
|
12.50
|
9.020
|
14.90
|
Announcement Date
|
26/04/19
|
30/04/20
|
30/04/21
|
29/04/22
|
01/03/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
375.6
|
392.4
|
380
|
575.8
|
652
|
562.6
|
EBITDA
1 |
26.12
|
29.04
|
32.51
|
24.52
|
14.14
|
62.87
|
EBIT
1 |
12.15
|
19.06
|
22.59
|
11.25
|
-0.753
|
35.12
|
Operating Margin
|
3.23%
|
4.86%
|
5.95%
|
1.95%
|
-0.12%
|
6.24%
|
Earnings before Tax (EBT)
1 |
7.744
|
15.3
|
14.77
|
7.046
|
-18.44
|
23.2
|
Net income
1 |
6.154
|
12.18
|
11.18
|
5.246
|
-16.97
|
18.3
|
Net margin
|
1.64%
|
3.1%
|
2.94%
|
0.91%
|
-2.6%
|
3.25%
|
EPS
2 |
0.8596
|
1.700
|
1.560
|
0.7358
|
-2.390
|
2.590
|
Free Cash Flow
1 |
7.106
|
5.87
|
1.17
|
13.13
|
4.448
|
33.39
|
FCF margin
|
1.89%
|
1.5%
|
0.31%
|
2.28%
|
0.68%
|
5.93%
|
FCF Conversion (EBITDA)
|
27.21%
|
20.21%
|
3.6%
|
53.54%
|
31.44%
|
53.11%
|
FCF Conversion (Net income)
|
115.47%
|
48.2%
|
10.46%
|
250.2%
|
-
|
182.43%
|
Dividend per Share
2 |
0.1400
|
0.3400
|
0.3500
|
-
|
-
|
-
|
Announcement Date
|
26/04/19
|
30/04/20
|
30/04/21
|
29/04/22
|
01/03/23
|
30/04/24
|
Fiscal Period: December |
2019 S1
|
2020 S1
|
2021 S1
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
---|
Net sales
1 |
202.6
|
-
|
277.2
|
-
|
178.2
|
141.1
|
EBITDA
1 |
-
|
-
|
23.14
|
-
|
12.05
|
16.9
|
EBIT
1 |
-
|
-
|
10.49
|
-
|
5.155
|
9.955
|
Operating Margin
|
-
|
-
|
3.78%
|
-
|
2.89%
|
7.06%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
5.752
|
-
|
-3.116
|
1.202
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
0.67%
|
-
|
EPS
|
-
|
0.8000
|
-
|
-0.4400
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/09/19
|
30/09/20
|
30/09/21
|
30/05/22
|
30/09/22
|
30/05/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
75
|
83.6
|
122
|
122
|
139
|
109
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.872
x
|
2.878
x
|
3.754
x
|
4.982
x
|
9.818
x
|
1.74
x
|
Free Cash Flow
1 |
7.11
|
5.87
|
1.17
|
13.1
|
4.45
|
33.4
|
ROE (net income / shareholders' equity)
|
5.58%
|
10.3%
|
8.77%
|
3.95%
|
-13.5%
|
14.5%
|
ROA (Net income/ Total Assets)
|
2.88%
|
4.3%
|
4.51%
|
1.84%
|
-0.12%
|
6.07%
|
Assets
1 |
213.6
|
282.9
|
248
|
285
|
14,245
|
301.6
|
Book Value Per Share
2 |
15.70
|
17.30
|
18.50
|
18.80
|
16.50
|
19.20
|
Cash Flow per Share
2 |
0.8300
|
0.6800
|
0.8600
|
3.140
|
0.5600
|
0.8300
|
Capex
1 |
14
|
18.1
|
44.5
|
11.1
|
8.78
|
9.95
|
Capex / Sales
|
3.73%
|
4.61%
|
11.7%
|
1.93%
|
1.35%
|
1.77%
|
Announcement Date
|
26/04/19
|
30/04/20
|
30/04/21
|
29/04/22
|
01/03/23
|
30/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +6.04% | 28M | | -19.34% | 1.76B | | +4.30% | 1.18B | | +0.74% | 995M | | -8.82% | 618M | | +48.19% | 597M | | +29.20% | 580M | | +7.92% | 265M | | -35.19% | 219M | | +19.13% | 213M |
Commodity Chemicals Wholesale
|